IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.903
EU - Europa 10.535
AS - Asia 6.022
SA - Sud America 1.288
AF - Africa 112
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 19
Totale 31.903
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.279
RU - Federazione Russa 4.135
SG - Singapore 3.087
IT - Italia 2.145
GB - Regno Unito 1.332
BR - Brasile 1.147
CN - Cina 1.145
DE - Germania 934
HK - Hong Kong 766
CA - Canada 520
IE - Irlanda 426
UA - Ucraina 412
VN - Vietnam 293
FI - Finlandia 230
SE - Svezia 200
FR - Francia 196
IN - India 137
NL - Olanda 123
TR - Turchia 114
AT - Austria 88
BD - Bangladesh 80
PK - Pakistan 76
MX - Messico 67
DK - Danimarca 64
PL - Polonia 57
ES - Italia 54
ID - Indonesia 54
AR - Argentina 52
IQ - Iraq 49
JP - Giappone 42
ZA - Sudafrica 41
AE - Emirati Arabi Uniti 34
UZ - Uzbekistan 27
LT - Lituania 26
CH - Svizzera 23
MA - Marocco 22
VE - Venezuela 21
BE - Belgio 20
CO - Colombia 18
EC - Ecuador 17
EU - Europa 17
RO - Romania 17
CZ - Repubblica Ceca 15
SA - Arabia Saudita 15
IR - Iran 14
AU - Australia 13
EG - Egitto 12
KE - Kenya 12
NZ - Nuova Zelanda 10
UY - Uruguay 10
AZ - Azerbaigian 9
JO - Giordania 9
TN - Tunisia 9
MC - Monaco 8
TW - Taiwan 7
AM - Armenia 6
CL - Cile 6
DZ - Algeria 6
IL - Israele 6
KR - Corea 6
NI - Nicaragua 6
PA - Panama 6
PE - Perù 6
PY - Paraguay 6
HU - Ungheria 5
NP - Nepal 5
OM - Oman 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BB - Barbados 4
CR - Costa Rica 4
GE - Georgia 4
JM - Giamaica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MY - Malesia 4
BO - Bolivia 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HN - Honduras 3
LB - Libano 3
PH - Filippine 3
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
MT - Malta 2
PS - Palestinian Territory 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
Totale 31.887
Salva come PNG Salva come JPEG
Città #
Singapore 1.838
Chicago 1.349
Beijing 843
Los Angeles 742
Hong Kong 711
Salt Lake City 589
Chandler 562
Southend 543
Ashburn 483
Fairfield 462
San Mateo 451
Moscow 434
Dublin 422
Woodbridge 359
Wilmington 351
Tampa 339
Houston 324
Cambridge 316
Buffalo 300
The Dalles 297
Seattle 276
Elk Grove Village 257
Portsmouth 242
Falls Church 237
Boardman 234
Munich 230
Stevenage 215
Ann Arbor 212
Milan 209
Ottawa 203
Beauharnois 193
Pisa 189
Rome 180
Jacksonville 179
Santa Clara 161
Dearborn 156
Lawrence 155
Dallas 136
Florence 130
Sterling 125
Lancaster 121
Dong Ket 117
New York 113
São Paulo 105
Brooklyn 103
London 101
Nuremberg 92
Frankfurt am Main 91
Miami 83
Helsinki 81
Dulles 77
Istanbul 71
Turku 65
San Diego 64
Lappeenranta 62
Detroit 50
Bologna 49
Kansas City 48
Warsaw 46
Boston 45
Phoenix 43
San Francisco 42
Washington 42
Fremont 38
Mexico City 38
Genoa 36
Palermo 36
Belo Horizonte 35
Livorno 35
Lucca 35
Toronto 35
Vienna 35
Central District 34
Pittsburgh 34
Naples 32
Tokyo 32
Guangzhou 31
Rio de Janeiro 31
Montreal 30
Atlanta 29
Amsterdam 28
Chennai 28
Düsseldorf 28
Charlotte 27
Assago 26
Redwood City 26
Ho Chi Minh City 25
Shanghai 25
Tashkent 24
Johannesburg 23
Las Vegas 23
New Delhi 23
Norwalk 23
Bari 22
Hangzhou 22
Stockholm 22
Ankara 21
Curitiba 21
Old Bridge 21
Turin 21
Totale 18.400
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.726
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.500
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.407
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 758
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 479
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 260
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 227
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 224
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 222
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 221
Treating chemoreflex in heart failure: modulation or demolition? 218
Building medical knowledge from real world registries: The case of heart failure 217
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 211
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 200
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 200
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 194
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 190
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 189
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 187
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 181
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 181
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 178
A simple echocardiographic score to rule out cardiac amyloidosis 177
Cardiac light-chain deposition disease relapsing in the transplanted heart 174
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 170
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 166
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 165
Sex-related differences in chronic heart failure 164
Unmet needs in end-of-life care for heart failure patients 162
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 162
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 159
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 158
How to take arms against central apneas in heart failure 152
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 147
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 146
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 145
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 142
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 142
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 141
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 138
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 135
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 134
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 134
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 133
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 131
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 131
A simple echocardiographic score to rule out cardiac amyloidosis 130
Cardiac troponins as biomarkers for cardiac disease 130
Screening the health status of people working in a university 128
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 128
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction 128
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 126
Biomarkers for the diagnosis and management of heart failure 126
Heart, kidney and FGF23: Les liaisons dangereuses 125
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 125
Amiodarone as a possible therapy for coronavirus infection 124
Atrial amyloidosis: mechanisms and clinical manifestations 123
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 122
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure 122
Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart 121
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 119
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 119
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 117
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 115
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 113
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 113
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 112
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis 112
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 111
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers 110
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 110
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 110
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 109
Eligibility for vericiguat in a real‐world, contemporary heart failure population 108
N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure 107
Management of complications of cardiac amyloidosis: 10 questions and answers 107
Cardiovascular disease and COVID-19: les liaisons dangereuses 107
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 107
Role of Imaging in Cardiomyopathies 106
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T 106
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 105
Subclinical cardiac damage in cancer patients before chemotherapy 105
Biomarkers for the diagnosis and management of heart failure: New frontiers 104
Polymorphisms in the eNOS gene and the risk of coronary artery disease: Making the case for genome-wide association studies 103
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week 103
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 103
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 102
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 101
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 101
Sex-related differences in chronic heart failure 101
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 101
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 101
The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) 100
Disease features and management of cardiomyopathies in women 99
Wet is bad: Residual congestion predicts worse prognosis in acute heart failure 98
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 98
Molecular autopsy of sudden cardiac death in the genomics era 98
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 97
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 97
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 97
Totale 18.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 231.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 231.683
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.162 0 209 96 208 108 321 143 129 217 158 252 321
2021/20222.538 177 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.303 220 243 878 362 665 803 1.951 3.264 1.352 2.531 4.186 2.848
2025/20262.513 2.194 319 0 0 0 0 0 0 0 0 0 0
Totale 32.281